ConductScience.org, home

Paper36230815

Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma.

Lamaison C and 10 others. Cancers (Basel), 2022. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma. Papers, record 36230815. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36230815

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.42
iCite
Revised in PubMed
2022-10-17
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lamaison CClaire
2Ferrant JJuliettehttps://orcid.org/0000-0003-2193-4104
3Gravelle PPauline
4Traverse-Glehen AAlexandra
5Ghesquières HHervé
6Tosolini MMarie
7Rossi CCédric
8Ysebaert LLoic
9Brousset PPierre
10Laurent CCamillehttps://orcid.org/0000-0002-5375-7512
11Syrykh CCharlottehttps://orcid.org/0000-0002-3201-6109

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132641598Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma.J Clin Exp Hematop2020https://conductscience.org/library/papers/32641598PubMed
227733358Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma.Blood2017https://conductscience.org/library/papers/27733358PubMed
325486870The IL-15 cytokine system provides growth and survival signals in Hodgkin lymphoma and enhances the inflammatory phenotype of HRS cells.Leukemia2015https://conductscience.org/library/papers/25486870PubMed
422667341Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.Leuk Lymphoma2013https://conductscience.org/library/papers/22667341PubMed
520959606CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.Blood2011https://conductscience.org/library/papers/20959606PubMed
626980727The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Blood2016https://conductscience.org/library/papers/26980727PubMed
72356855Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.Am J Pathol1990https://conductscience.org/library/papers/2356855PubMed
820220182Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.N Engl J Med2010https://conductscience.org/library/papers/20220182PubMed
925482239PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.N Engl J Med2015https://conductscience.org/library/papers/25482239PubMed
1027737878Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status.Cancer Immunol Res2016https://conductscience.org/library/papers/27737878PubMed
1126406983Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.PLoS One2015https://conductscience.org/library/papers/26406983PubMed
1211154228Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.Blood2001https://conductscience.org/library/papers/11154228PubMed
1319096012Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.Blood2009https://conductscience.org/library/papers/19096012PubMed
1418924115Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.Hematol Oncol2009https://conductscience.org/library/papers/18924115PubMed
1523045593Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.J Clin Oncol2013https://conductscience.org/library/papers/23045593PubMed
1633567641Genomic Landscape of Hodgkin Lymphoma.Cancers (Basel)2021https://conductscience.org/library/papers/33567641PubMed
1711159538Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease.Blood2001https://conductscience.org/library/papers/11159538PubMed
1824766492CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.Leuk Lymphoma2015https://conductscience.org/library/papers/24766492PubMed
1933936943Impact of cluster of differentiation 20 expression and rituximab therapy in classical Hodgkin lymphoma: Real world experience.Leuk Res Rep2021https://conductscience.org/library/papers/33936943PubMed
2032352505Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.JAMA Oncol2020https://conductscience.org/library/papers/32352505PubMed

See all 43 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42654466Quantity Does Not Matter: Number, Ratio, or Grouping of Hodgkin/Reed-Sternberg Cells Does Not Affect Prognosis in Patients with Classic Hodgkin Lymphoma.Medicina (Kaunas)2026https://conductscience.org/library/papers/42654466PubMed
39669843A Decade of Prevalence and Clinicopathological Insights Into Classical Hodgkin Lymphoma: A Study From an Indonesian Tertiary Hospital.Cureus2024https://conductscience.org/library/papers/39669843PubMed
39517391Unusual Signal of Lymphadenopathy in Children with Nodular Sclerosing Hodgkin Lymphoma.Healthcare (Basel)2024https://conductscience.org/library/papers/39517391PubMed
37345063Hodgkin Lymphoma-The Spectrum from Diagnostics to Molecular Science, Movement and Current Treatment Approaches.Cancers (Basel)2023https://conductscience.org/library/papers/37345063PubMed

Download CSV of cited by

Genes52

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
CCL196363PubTator's text mininghttps://conductscience.org/library/genes/6363NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD3D915PubTator's text mininghttps://conductscience.org/library/genes/915NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD74972PubTator's text mininghttps://conductscience.org/library/genes/972NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CD81975PubTator's text mininghttps://conductscience.org/library/genes/975NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CD994267PubTator's text mininghttps://conductscience.org/library/genes/4267NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CTSC1075PubTator's text mininghttps://conductscience.org/library/genes/1075NCBI Gene
CTSS1520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
CXCL94283PubTator's text mininghttps://conductscience.org/library/genes/4283NCBI Gene
CXCR32833PubTator's text mininghttps://conductscience.org/library/genes/2833NCBI Gene
GBP12633PubTator's text mininghttps://conductscience.org/library/genes/2633NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
HLA-DPA13113PubTator's text mininghttps://conductscience.org/library/genes/3113NCBI Gene

See all 52 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36230815

GET https://conductscience.org/api/papers/v1/36230815/references?page=2